ArticleOncotarget2018
Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.
Gustavo A Arias-Pinilla et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it